Xuanzhu and SignalChem Lifesciences enter licensing agreement
The agreement covers the development and commercialisation of AXL targeting inhibitor SLC-391 in the Greater China Region
Breaking News
BioAscent reports increasing demand for compound management
Throughout the last two years the company has invested over £1m in its compound management infrastructure and grown ...
F-star Therapeutics announces license agreement with Janssen
The agreement grants Janssen an exclusive license to research, develop, and commercialise bispecific antibodies ...
Tjoapack expands into NA with PPS acquisition
"The acquisition supports Tjoapack’s growth strategy and is indicative of our commitment to customers”
Remediating pharmaceutical quality systems
Much of our work involves helping companies remediate flawed quality systems. Find out the factors that can make your ...
CrystecPharma and Biosidus collaborate on biotherapeutics
The first programme in the cooperation will develop a dry powder preparation of teriparatide for the treatment of ...
Enesi Pharma and NIAID to test novel flu vaccines
The vaccines will be developed using Enesi Pharma’s ImplaVax technology
Beximco Pharma: The Bangladeshi company connecting with the US
COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market
KeyPlants acquires Swedish modular workshop partner
The acquisition will strengthen the company’s modular workshop capabilities and support its ability to offer ...
Touchlight to break ground on high-capacity DNA facility
Once operational in 2022, the facility will have the capacity to manufacture up to 1 kg of GMP DNA per month
What does a pharmaceutical integrated services programme entail?
Here Kevin Duffield, Head of Client Services North America/United Kingdom discusses key attributes to look for in an ...
Addressing the need for cost-effective vaccine manufacturing
Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost- ...
Operational excellence: Delivering value to customers, patients and shareholders
Here Manoj Zalpuri, Gourav Bajpai and Shivam Saxena at Piramal Pharma Solutions discuss the benefits of a holistic ...
Merck opens viral vector CDMO facility in Carlsbad
This is the company’s second Carlsbad, California-based facility to serve cell and gene therapy customers
Navigo Proteins announces extension of partnership with ITM
Through the partnership, the company is developing targeted radiopharmaceutical candidates for the treatment of cancer
In Brief
Most Popular in Finance
Reports
